Zai Lab Appoints Richard Gaynor, MD, to its Board of Directo

SHANGHAI and SAN FRANCISCO and CAMBRIDGE, Mass., Nov. 22, 2021 (GLOBE NEWSWIRE) -- Zai Lab Limited (NASDAQ: ZLAB; HKEX: 9688), a patient-focused, innovative, commercial-stage, global biopharmaceutical company, announced today that

Related Keywords

China , Shanghai , Cambridge , Cambridgeshire , United Kingdom , Richard Gaynor , Scott Morrison , Ron Aldridge , Alina Zhang , Danielle Halstrom Xiaoyu Chen , School Of Medicine , Zai Lab Safe Harbor , Zai Lab , Zai Lab Limited , Simmons Cancer Center , University Of Texas Southwestern Medical School , Nasdaq , Astrazeneca , Bristol Myers Squibb , Clinical Development , Ge Healthcare , Infinity Pharmaceuticals , Development Of Biontech , Alkermes , Zai Lab Board , Development Committee , Exchange Commission , Damon Runyon Cancer Research Foundation , Zai Lab Board Of Directors Dr , Lilly Oncology Research , Zai Lab Board Of Directors , Lab Limited , Neon Therapeutics , Lilly Oncology , Senior Vice President , Texas Southwestern Medical School , Simmons Cancer , Damon Runyon Cancer Research , Chief Executive Officer , Lab Safe Harbor This , Private Securities Litigation Reform Act , Danielle Halstrom , Xiaoyu Chen , Money , Ational ,